Drugs / GSK232802
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00604825 Comparator | Jul 2007 → Jul 2008 | — | GlaxoSmithKline | Completed | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK232802 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00604825 ↗ |
| Modality | Small molecule | — CHEMBL4297493 ↗ |
| Route | Oral | “GSK232802 Administered Orally” NCT00604825 ↗ |